Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Department of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.
J Ethnopharmacol. 2018 Jun 12;219:81-90. doi: 10.1016/j.jep.2017.12.013. Epub 2017 Dec 14.
Zhen-wu-tang (ZWT), composed of Radix Aconiti lateralis, Rhizoma Atractylodis macrocephalae, Poria, Radix Paeoniae alba and ginger, is a classic Chinese herbal formula for the treatment of chronic kidney diseases that may cause chronic renal failure (CRF).
To better understand its clinical use, this study investigated the effects and underlying mechanisms of action of ZWT on CRF.
CRF was induced by adenine. ZWT was given via an oral gavage method. The serum biochemical parameters were measured enzymatically or by ELISA. The kidneys were examined pathohistologically. The gene expression was analyzed by real time PCR and Western blot.
Similar to the positive control losartan, ZWT extract inhibited adenine-induced increase in serum concentrations of creatinine, BUN and advanced oxidation protein products in rats. These effects were accompanied by attenuation of proteinuria and renal pathological changes and suppression of renal mRNA and protein overexpression of Collagen IV and fibronectin, two of the key components of fibrosis. Mechanistically, renal mRNA and protein expression of Wnt4, a Wnt signaling ligand, was increased in the adenine-treated group, compared to the vehicle-treated control. Consistently, Wnt4 downstream genes beta-catenin and Axin were also overexpressed. Treatment with ZWT extract and losartan suppressed adenine-stimulated overexpression of these mRNAs and proteins.
The present results demonstrate that ZWT extract ameliorates adenine-induced CRF in rats by regulation of the canonical Wnt4/beta-catenin signaling in the kidneys. Our findings provide new insight into the underlying renoprotective mechanisms of the ancient formula.
真武汤(ZWT)由乌头、白术、茯苓、白芍和生姜组成,是一种经典的中药方剂,用于治疗可能导致慢性肾衰竭(CRF)的慢性肾病。
为了更好地了解其临床应用,本研究探讨了真武汤对 CRF 的作用及其作用机制。
用腺嘌呤诱导 CRF。真武汤通过口服灌胃法给予。血清生化参数通过酶法或 ELISA 测定。肾脏进行病理组织学检查。通过实时 PCR 和 Western blot 分析基因表达。
与阳性对照氯沙坦类似,真武汤提取物抑制腺嘌呤诱导的大鼠血清肌酐、BUN 和晚期氧化蛋白产物浓度升高。这些作用伴随着蛋白尿和肾脏病理变化的减轻以及胶原 IV 和纤维连接蛋白等纤维化关键成分的 mRNA 和蛋白过度表达的抑制。在机制上,与 vehicle 处理对照组相比,腺嘌呤处理组肾脏 Wnt4(一种 Wnt 信号配体)的 mRNA 和蛋白表达增加。真武汤提取物和氯沙坦的治疗抑制了这些 mRNA 和蛋白的腺嘌呤刺激过度表达。
本研究结果表明,真武汤提取物通过调节肾脏中的经典 Wnt4/β-catenin 信号通路改善腺嘌呤诱导的大鼠 CRF。我们的发现为古老配方的潜在肾保护机制提供了新的见解。